Sep 17, 2026 06:30AM
Sep 17, 2026 06:30AM
Aug 5, 2026 08:01AM
Jul 13, 2026 08:02AM
Jul 13, 2026 08:01AM
Jul 6, 2026 09:25AM
Jul 6, 2026 09:25AM Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Jun 26, 2026 08:02AM
Jun 26, 2026 08:01AM
Jun 26, 2026 07:00AM
Jun 10, 2026 04:15PM
Jun 2, 2026 08:01AM
May 21, 2026 08:02AM
May 21, 2026 08:01AM Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
Mar 24, 2026 10:30AM
Feb 4, 2026 08:01AM
Dec 2, 2025 08:02AM
Dec 2, 2025 08:01AM
Oct 8, 2025 07:00AM
Sep 4, 2025 07:00AM
Jun 26, 2025 04:15PM Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update
Jun 20, 2025 08:01AM
Jun 18, 2025 08:01AM
Jun 9, 2025 08:01AM
May 14, 2025 08:01AM
Mar 10, 2025 08:01AM
Feb 13, 2025 08:01AM
Feb 12, 2025 04:15PM Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update
Feb 5, 2025 08:01AM
Jan 29, 2025 08:04AM
Jan 29, 2025 08:01AM
Dec 20, 2024 08:02AM
Dec 20, 2024 08:01AM
Nov 14, 2024 08:00AM
Nov 13, 2024 04:15PM Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
Nov 12, 2024 08:00AM
Nov 11, 2024 08:01AM
Nov 6, 2024 08:01AM
Oct 8, 2024 08:01AM
Sep 19, 2024 10:00AM
Sep 19, 2024 08:01AM
Sep 19, 2024 08:01AM Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
Sep 17, 2024 08:01AM
Sep 17, 2024 07:30AM
Sep 16, 2024 08:14AM
Sep 16, 2024 08:01AM
Sep 13, 2024 08:35AM
Aug 27, 2024 08:12AM
Aug 27, 2024 08:01AM Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rew
Aug 14, 2024 04:15PM

331,677 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All